{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:56:27Z","timestamp":1775609787791,"version":"3.50.1"},"reference-count":31,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"unspecified","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["Reserach for Patient Benefit (RfPB) PB-PG-0418-200"],"award-info":[{"award-number":["Reserach for Patient Benefit (RfPB) PB-PG-0418-200"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Antimicrobial resistance is rising, largely due to the indiscriminate use of antimicrobials. The human gut is the largest reservoir of antibiotic resistant bacteria (ARB). Individuals colonised with ARB have the potential to spread these organisms both in the community and hospital settings. Infections with ARB such as extended spectrum beta-lactamase producing enterobacteriales (ESBL-E) and carbapenemase producing enterobacteriales (CPE) are more difficult to treat and are associated with an increased morbidity and mortality. Presently, there is no effective decolonisation strategy for these ARB. Faecal microbiota transplant (FMT) has emerged as a potential strategy for decolonisation of ARB from the human gut, however there is significant uncertainty about the feasibility, effectiveness and safety of using this approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>Prospective, randomised, patient-blinded, placebo-controlled feasibility trial of FMT to eradicate gastrointestinal carriage of ARB. Eighty patients with a recent history of invasive infection secondary to ESBL-E or CPE and persistent gastrointestinal carriage will be randomised 1:1 to receive encapsulated FMT or placebo. The primary outcome measure is consent rate (as a proportion of patients who fulfil inclusion\/exclusion criteria); this will be used to determine if a substantive trial is feasible. Participants will be followed up at 1\u2009week, 1\u2009month, 3 months and 6 months and monitored for adverse events as well as gastrointestinal carriage rates of ARB after intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>Research ethics approval was obtained by London\u2014City and East Research Ethics Committee (ref 20\/LO\/0117). Trial results will be published in a peer-reviewed journal and presented at international conferences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>ISRCTN registration number 34\u2009467\u2009677 and EudraCT number 2019-001618-41.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2020-038847","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T10:15:28Z","timestamp":1590488128000},"page":"e038847","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organisms (FERARO): a prospective, randomised placebo-controlled feasibility trial"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6061-6064","authenticated-orcid":false,"given":"Blair","family":"Merrick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6692-5415","authenticated-orcid":false,"given":"Emily","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0935-3713","authenticated-orcid":false,"given":"Catey","family":"Bunce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liz","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Bisnauthsing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Chi","family":"Izundu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordana","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Amos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manu","family":"Shankar-Hari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie L","family":"Shawcross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0837-7382","authenticated-orcid":false,"given":"Simon D","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,5,25]]},"reference":[{"key":"2020052603150898000_10.5.e038847.1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cmi.2019.02.026","article-title":"Individual- and community-level risk factors for ESBL Enterobacteriaceae colonization identified by universal admission screening in London","volume":"25","author":"Otter","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2020052603150898000_10.5.e038847.2","unstructured":"Public Health England . English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report, 2019."},{"key":"2020052603150898000_10.5.e038847.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4387-3","article-title":"Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017","volume":"19","author":"Gupta","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2020052603150898000_10.5.e038847.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-099(18)30605-4"},{"key":"2020052603150898000_10.5.e038847.5","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01730-17","article-title":"A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant Enterobacteriaceae","volume":"62","author":"van Loon","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020052603150898000_10.5.e038847.6","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.6.2000085","article-title":"Prolonged outbreak of new Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019","volume":"25","author":"Tavoschi","year":"2020","journal-title":"Euro Surveill"},{"key":"2020052603150898000_10.5.e038847.7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01689-18","article-title":"A large, refractory nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Escherichia coli demonstrates carbapenemase gene outbreaks involving sink sites require novel approaches to infection control","volume":"62","author":"Decraene","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020052603150898000_10.5.e038847.8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1017\/ice.2019.155","article-title":"Attributable mortality due to fluoroquinolone and extended-spectrum cephalosporin resistance in hospital-onset Escherichia coli and Klebsiella spp bacteremia: a matched cohort study in 129 Veterans health administration medical centers","volume":"40","author":"Suzuki","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020052603150898000_10.5.e038847.9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jhin.2016.10.006","article-title":"Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review","volume":"95","author":"French","year":"2017","journal-title":"J Hosp Infect"},{"key":"2020052603150898000_10.5.e038847.10","doi-asserted-by":"publisher","DOI":"10.1086\/422002"},{"key":"2020052603150898000_10.5.e038847.11","doi-asserted-by":"crossref","DOI":"10.1186\/2047-2994-1-39","article-title":"The gut is the epicentre of antibiotic resistance","volume":"1","author":"Carlet","year":"2012","journal-title":"Antimicrob Resist Infect Control"},{"key":"2020052603150898000_10.5.e038847.12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.120.5.805"},{"key":"2020052603150898000_10.5.e038847.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205037"},{"key":"2020052603150898000_10.5.e038847.14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5694\/mja17.00295","article-title":"Faecal microbiota transplantation for <em>Clostridium difficile<\/em>-associated diarrhoea: a systematic review of randomised controlled trials","volume":"207","author":"Moayyedi","year":"2017","journal-title":"Med J Aust"},{"key":"2020052603150898000_10.5.e038847.15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.cmi.2019.01.005","article-title":"ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant gram-negative bacteria carriers","volume":"25","author":"Tacconelli","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2020052603150898000_10.5.e038847.16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.cmi.2019.04.006","article-title":"Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review","volume":"25","author":"Saha","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2020052603150898000_10.5.e038847.17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MOG.0000000000000596","article-title":"Carbapenemase-producing Enterobacteriaceae - once positive always positive?","volume":"36","author":"Vink","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"key":"2020052603150898000_10.5.e038847.18","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.cmi.2018.12.009","article-title":"A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial","volume":"25","author":"Huttner","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2020052603150898000_10.5.e038847.19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir632"},{"key":"2020052603150898000_10.5.e038847.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023518"},{"key":"2020052603150898000_10.5.e038847.21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40121-018-0189-y","article-title":"Comparison of different strategies for providing fecal microbiota transplantation to treat patients with recurrent Clostridium difficile infection in two English hospitals: a review","volume":"7","author":"Goldenberg","year":"2018","journal-title":"Infect Dis Ther"},{"key":"2020052603150898000_10.5.e038847.22","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2164"},{"key":"2020052603150898000_10.5.e038847.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.07.011"},{"key":"2020052603150898000_10.5.e038847.24","doi-asserted-by":"crossref","unstructured":"Woodworth MH , Hayden MK , Young VB , et al . The role of fecal microbiota transplantation in reducing intestinal colonization with antibiotic-resistant organisms: the current landscape and future directions. Open Forum Infect Dis 2019;6.","DOI":"10.1093\/ofid\/ofz391"},{"key":"2020052603150898000_10.5.e038847.25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhin.2019.03.010","article-title":"Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut: a systematic review and meta-analysis","volume":"102","author":"Tavoukjian","year":"2019","journal-title":"J Hosp Infect"},{"key":"2020052603150898000_10.5.e038847.26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijantimicag.2019.03.008","article-title":"Fifty shades of graft: how to improve the efficacy of faecal microbiota transplantation for decolonization of antibiotic-resistant bacteria","volume":"53","author":"Davido","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"2020052603150898000_10.5.e038847.27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhin.2019.04.012","article-title":"Screening for carbapenemase-producing Enterobacteriaceae in previous carriers readmitted to hospital: evaluation of a change in screening policy","volume":"103","author":"Tucker","year":"2019","journal-title":"J Hosp Infect"},{"key":"2020052603150898000_10.5.e038847.28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.001"},{"key":"2020052603150898000_10.5.e038847.29","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.03.045"},{"key":"2020052603150898000_10.5.e038847.30"},{"key":"2020052603150898000_10.5.e038847.31","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1016\/S0016-5085(17)30969-1","article-title":"Short duration, low intensity, pooled fecal microbiota transplantation induces remission in patients with Mild-Moderately active ulcerative colitis: a randomised controlled trial","volume":"152","author":"Costello","year":"2017","journal-title":"Gastroenterology"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-038847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T22:48:47Z","timestamp":1666651727000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-038847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,25]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1136\/bmjopen-2020-038847"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-038847","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}